Type I interferons are essential mediators of apoptotic death in virally infected cells

Genes to Cells

Volumn 3, Issue 1, 1998, Pages 29-37

  Tanaka, Nobuyuki ^a   Sato, Mitsuharu ^a   Lamphier, Marc S ^a,b   Nozawa, Hiroaki ^a   Oda, Eri ^a   Noguchi, Shigeru ^c   Schreiber, Robert D ^d   Tsujimoto, Yoshihide ^e   Taniguchi, Tadatsugu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c MEIJI DAIRIES CORPORATION   (Japan)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE ANTIBODY; DOUBLE STRANDED RNA; FAS ANTIGEN; IMMUNOGLOBULIN G; INTERFERON; INTERLEUKIN 6 ANTIBODY; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EMBRYO; FIBROBLAST CULTURE; HERPES SIMPLEX VIRUS; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

ANIMALS; ANTIBODIES; ANTIVIRAL AGENTS; APOPTOSIS; DNA-BINDING PROTEINS; ENCEPHALOMYOCARDITIS VIRUS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE I; MEMBRANE PROTEINS; MICE; POLY I-C; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; RNA, DOUBLE-STRANDED; SIGNAL TRANSDUCTION; SIMPLEXVIRUS; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; VESICULAR STOMATITIS-INDIANA VIRUS;

ANIMALIA; HERPES; SIMPLEXVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0031925470     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2443.1998.00164.x     Document Type: Article

References (44)

1. Bluyssen, A.R., Durbin, J.E. & Levy, D.E. (1996) ISGF3γ p48, a specificity switch for interferon activated transcription factors. Cytokine Growth Factor Rev. 7, 11-17.
2. Chin, Y.E., Kitagawa, M., Kuida, K., Flavell, R.A. & Fu, X.Y. (1997) Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 17, 5328-5337.
3. Darnell, J.E., Jr, Kerr, I.M. & Stark, G.R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
4. De Maeyer, E. & De Maeyer-Guignard, J. (1988) Interferons and Other Regulatory Cytokines. New York: John Wiley and Sons.
5. Der, S.D., Yang, Y.L., Weissmann, C. & Williams, B.R. (1997) A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 3279-3283.
6. Durbin, J.E., Hackenmiller, R., Simon, M.C. & Levy, D.E. (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450.
7. Fauci, A.S. (1996) Host factors and the pathogenesis of HIV-induced disease. Nature 384, 529-534.
8. Gavrieli, Y., Sherman, Y. & Ben-Sasson, S.A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501.
9. Hardwick, J.M. (1997) Virus-induced apoptosis. Adv. Pharmacol. 41, 295-336.
10. Henderson, S., Huen, D., Rowe, M., et al. (1993) Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA 90, 8479-8483.
11. Henderson, S., Rowe, M., Gregory, C., et al. (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65, 1107-1115.
12. Hinshaw, V.S., Olsen, C.W., Dybdahl-Sissoko, N. & Evans, D. (1994) Apoptosis: a mechanism of cell killing by influenza A and B viruses. J. Virol. 68, 3667-3673.
13. Hoofnagle, J.H. (1994) Therapy of acute and chronic viral hepatitis. Adv. Intern. Med. 39, 241-275.
14. Hoofnagle, J.H. & di Bisceglie, A.M. (1997) The treatment of chronic viral hepatitis. N. Engl. J. Med. 336, 347-356.
15. Kagi, D., Ledermann, B., Burki, K., Zinkernagel, R.M. & Hengartner, H. (1996) Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14, 207-232.
16. Kimura, T., Kadonaga, Y., Harada, H., et al. (1996) Essential and non-redundant roles of p48 (ISGF3γ) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells 1, 115-124.
17. Kimura, T., Nakayama, K., Penninger, J., et al. (1994) Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264, 1921-1924.
18. Korsmeyer, S.J. (1995) Regulators of cell death. Trends Genet. 11, 101-105.
19. Lengyel, P. (1987) Double-stranded RNA and Interferon action. J. Interferon Res. 7, 511-519.
20. Levine, B., Huang, Q., Isaacs, J.T., et al. (1993) Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361, 739-742.
21. Levine, A.J., Momand, J. & Finlay, C.A. (1991) The p53 tumour suppressor gene. Nature 351, 453-456.
22. Lokshin, A., Mayotte, J.E. & Levitt, M.L. (1995) Mechanism of interferon beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines. J. Natl. Cancer Inst. 87, 206-212.
23. Matsuyama, T., Kimura, T., Kitagawa, M., et al. (1993) Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75, 83-97.
24. Medzhitov, R. & Janeway, C.A., Jr (1997) Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9, 4-9.
25. Meraz, M.A., White, J.M., Sheehan, K.C., et al. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442.
26. Müller, U., Steinhoff, U., Reis, L.F.L., et al. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264, 1918-1921.
27. Nagata, S. & Golstein, P. (1995) The Fas death factor. Science 267, 1449-1456.
28. Pestka, S., Langer, A.J., Zoon, K. & Samuel, C. (1987) Interferons and their actions. Annu. Rev. Biochem. 56, 727-777.
29. Razvi, E.S. & Welsh, R.M. (1995) Apoptosis in viral infections. Adv. Virus Res. 45, 1-60.
30. Reis, L.F.L., Ruffner, H., Stark, G., Aguet, M. & Weissmann, C. (1994) Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. EMBO J. 13, 4798-4806.
31. Rodriguez-Villanueva, J. & McDonnell, T.J. (1995) Induction of apoptotic cell death in non-melanoma skin cancer by interferon-alpha. Int. J. Cancer 61, 110-114.
32. Savill, J., Dransfield, I., Hogg, N. & Haslett, C. (1990) Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343, 170-173.
33. Sen, G.C. & Ransohoff, R.M. (1993) Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42, 57-102.
34. Shen, Y. & Shenk, T.E. (1995) Viruses and apoptosis. Curr. Opin. Genet. Dev. 5, 105-111.
35. Stewart, W.E.I., De Clercq, E., Billiau, A., Desmyter, J. & De Somer, P. (1972) Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic-polyribocytidylic acid. Proc. Natl. Acad. Sci. USA 69, 1851-1854.
36. Stewart, W.E.I., De Clercq, E. & De Somer, P. (1973) Specificity of interferon-induced enhancement of toxicity for double-stranded ribonucleic acids. J. Gen. Virol. 18, 237-246.
37. Tamura, T., Ishihara, M., Lamphier, M.S., et al. (1995) An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376, 596-599.
38. Taniguchi, T., Lamphier, M.S. & Tanaka, N. (1997) IRF-1; the transcription factor linking the interferon response and oncogenesis. BBA: Rev. Cancer 1333, M9-M17.
39. Thome, M., Schneider, P., Hofmann, K., et al. (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386, 517-521.
40. Vermes, I., Haanen, C., Steffens-Nakken, H. & Reutelingsperger, C. (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Meth. 184, 39-51.
41. Vilcek, J. & Sen, G.S. (1996) Interferons and other cytokines. In: Fields Virology (eds D.M. Fields, P.M. Knipe & P.M. Howley), 3rd edn, pp. 375-399. Philadelphia, PA: Lippincott-Raven.
42. Vogelstein, B. & Kinzler, K.W. (1992) p53 function and dysfunction. Cell 70, 523-526.
43. Zhou, A., Paranjape, J., Brown, T.L., et al. (1997) Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L. EMBO J. 16, 6355-6363.
44. Zinkernagel, R.M. & Hengartner, H. (1997) Antiviral immunity. Immunol. Today 18, 258-260.